NL-OMON21334
Not yet recruiting
Not Applicable
Early pharmacological intervention to prevent delirium: Haloperidol prophylaxis in older emergency department patients.
VU Univeristy Medical Center Amsterdam0 sites600 target enrollmentTBD
ConditionsDelirium
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Delirium
- Sponsor
- VU Univeristy Medical Center Amsterdam
- Enrollment
- 600
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients age 70 years or over;
- •2\. First presentation in the ED in the last month;
Exclusion Criteria
- •1\. Patients presenting in the ED with delirium according to the DSM\-IV criteria;
- •2\. Patients with clinically significant cardiac disorders:
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Early pharmacological intervention to prevent delirium: HAlopeRidol PrOphylaxis in Older emergency department patieNts. The HARPOON studyacute state of confusiondelierDelirium10012221NL-OMON39657Vrije Universiteit Medisch Centrum780
Active, not recruiting
Not Applicable
An early treatment with haloperiodl to prevent acute confusion in older patients who are acutely admitted to the hospital.DeliriumTherapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]EUCTR2011-004762-15-NLVU Univeristy Medical Centre
Completed
Phase 4
Haloperidol Prophylaxis in Older Emergency Department PatientsDeliriumNCT01530308Amsterdam UMC, location VUmc242
Completed
Not Applicable
Early Detection and Pharmacological Intervention for exercise-induced or cold-pressor-induced PHexercise-induced pulmonary hypertension, cold-pressor-induced pulmonary hypertensionJPRN-UMIN000029928Mie University Graduate School of Medicine Department of Cardiology and Nephrology50
Active, not recruiting
Not Applicable
A new therapeutic approach to prevent acute complications in type 2 diabetes: The effect of the combination of the GLP-1 Analog Liraglutide and Insulin LEvemir® against the cOnventional insulin therapy: GALILEOdiabetes mellitus type 2, inadequate metabolic control, indication for insulin therapymyocardial lipid accumulation and left-ventricular function, retinal changes, microabluminuria, beta-cell-function, endothelial dysfunctionMedDRA version: 14.1Level: PTClassification code 10012607Term: Diabetes mellitus inadequate controlSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 14.1Level: PTClassification code 10012689Term: Diabetic retinopathySystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 14.1Level: HLTClassification code 10012654Term: Diabetic complications cardiovascularSystem Organ Class: 10014698 - Endocrine disordersMedDRA version: 14.1Level: PTClassification code 10012647Term: Diabetic cardiomyopathySystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 14.1Level: HLTClassification code 10012658Term: Diabetic complications renalSystem Organ Class: 10014698 - Endocrine disordersMedDRA version: 14.1Level: HLTClassification code 10012657Term: Diabetic complications ophthalmicSystem Organ Class: 10014698 - Endocrine disordersMedDRA version: 14.1Level: PTClassification code 10054044Term: Diabetic microangiopathySystem Organ Class: 10047065 - Vascular disordersMedDRA version: 14.1Level: HLGTClassification code 10012653Term: Diabetic complicationsSystem Organ Class: 10014698 - Endocrine disordersTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2012-001208-39-ATMedizinische Universität Wien, Univ.Klinik für Innere Medizin III, Abt.f.Endokrinologie und Stoffwechsel